Karah Herdman Parschauer is EVP and Chief Legal Officer of Ultragenyx Pharmaceutical Inc.
Person profile
Roles
Ultragenyx Pharmaceutical
EVP and Chief Legal Officer
Evolus
Director
Tenaya Therapeutics
Director
Anebulo Pharmaceuticals
Director
Address
Novato, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Ultragenyx Pharmaceutical Inc.
3 Mar 23
4
Evolus, Inc.
31 Jan 23
4
Anebulo Pharmaceuticals, Inc.
3 Oct 22
4
Tenaya Therapeutics, Inc.
9 Sep 22
4
Ultragenyx Pharmaceutical Inc.
8 Mar 22
4
Ultragenyx Pharmaceutical Inc.
3 Mar 22
4
Evolus, Inc.
26 Jan 22
4
Tenaya Therapeutics, Inc.
23 Dec 21
3
Tenaya Therapeutics, Inc.
23 Dec 21
4
Ultragenyx Pharmaceutical Inc.
18 Oct 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Mar 23 | RARE Ultragenyx Pharmaceutical | Common Stock | Sell | Dispose S | No | No | 45.25 | 3,161 | 143.04 k | 56,139 |
1 Mar 23 | RARE Ultragenyx Pharmaceutical | Common Stock | Grant | Acquire A | No | No | 0 | 22,000 | 0.00 | 59,101 |
1 Mar 23 | RARE Ultragenyx Pharmaceutical | Common Stock | Grant | Acquire A | No | No | 0 | 2,663 | 0.00 | 37,101 |
1 Mar 23 | RARE Ultragenyx Pharmaceutical | Stock Option Common Stock | Grant | Acquire A | No | No | 45.65 | 39,400 | 1.80 mm | 39,400 |
27 Jan 23 | EOLS Evolus | Common Stock | Grant | Acquire A | No | No | 0 | 8,293 | 0.00 | 43,174 |
27 Jan 23 | EOLS Evolus | Stock Option Common Stock | Grant | Acquire A | No | No | 10.25 | 11,789 | 120.84 k | 11,789 |
8 Sep 22 | TNYA Tenaya Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 4.82 | 20,000 | 96.40 k | 20,000 |
21 Apr 22 | ANEB Anebulo Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 6 | 30,425 | 182.55 k | 30,425 |
7 Mar 22 | RARE Ultragenyx Pharmaceutical | Common Stock | Sell | Dispose S | No | No | 62.95 | 5,140 | 323.56 k | 34,438 |